At COP31 in Antalya, the economic case for protecting health is becoming harder for finance ministers to dismiss. A new World Health Organization analysis estimates that scaling up six climate-health actions could prevent 1.6 million deaths a year globally. Across five of those actions, the estimated benefit is US$24 for every dollar invested.
That is a compelling argument for action. It also invites a question: how should Canada account for the benefits of protecting the way people think, learn, remember and function?
Lives saved must remain central to climate policy. But survival is not the whole measure of health. A person can survive a stroke and need years of rehabilitation. A family can navigate a smoke emergency while struggling to maintain care for someone with dementia. These experiences matter even when they do not appear in a headline death toll.
This is not an argument that WHO has ignored every non-fatal outcome. Its analysis includes economic impacts such as productivity, and its public summary describes health impacts as primarily changes in mortality. Nor are its global projections a ready-made estimate of Canadian savings. They are a reason to ask more carefully which benefits our own investment decisions capture, which they leave uncertain, and which they do not measure.
There is already evidence worth taking seriously. A review and meta-analysis in the Journal of the American Heart Association associated long-term exposure to fine particulate pollution with increased stroke incidence. A Canadian-led review in Neurology found an association between that pollution and dementia incidence, while warning about substantial differences among studies.
Neither finding means that every case is caused by climate change. Particulate pollution has many sources; an association is not proof of causation; and estimates for one population cannot simply be transferred to another. These distinctions should strengthen the case for better measurement, not become excuses for leaving brain health out of the discussion.
The practical response is to build evaluation into adaptation spending. When governments invest in cleaner indoor air, cooling or heat warnings, they should ask which neurological and mental-health outcomes can be assessed reliably alongside established measures of illness and mortality. Where evidence is too limited to support a dollar figure, the uncertainty should be reported, not converted into either a speculative benefit or an assumed zero.
Canada could start with three changes.
First, connect environmental monitoring with existing health research and surveillance, with privacy safeguards and community control over participation. Public-health teams and researchers could examine whether heat and pollution patterns coincide with changes in stroke admissions, neurological care or mental-health service use. Such work needs appropriate comparison groups and attention to other explanations, rather than simply counting events after a hot or smoky day.
Second, test protection, not only harm. Evaluations of cooling and cleaner-air programs should specify the outcomes they expect to improve, measure who can actually use them and publish results even when benefits are smaller than hoped. The relevant question is not whether a program sounds brain-friendly; it is whether it helps people, for whom, and at what cost.
Third, make the accounting explicit. Separate healthcare spending from lost paid work, unpaid caregiving and reduced quality of life. Avoid adding overlapping estimates together. Show the assumptions and plausible ranges, so decision-makers can see what rests on strong evidence and what remains a research question.
There is a reasonable objection: adaptation budgets are already stretched, and every extra indicator can add cost and delay. The answer is not a vast new reporting bureaucracy; it is a focused set of questions added to programs and data systems that already exist, chosen with clinicians, researchers and affected communities. Better evidence should improve decisions, not postpone well-supported protections while we wait for perfect certainty.
The ethical boundary matters, too. A child’s ability to learn, the autonomy of someone living with dementia and a caregiver’s well-being have value beyond their contribution to gross domestic product. Economic analysis can help compare investments; it cannot decide whose life deserves protection.
At WHO’s COP31 ministerial roundtable, the message was clear: declarations need implementation. Canada should take that seriously by funding protection and evaluating what it achieves. Brain health belongs in that work, with neither inflated promises nor convenient omissions.
Climate policy helps shape the conditions in which we think and live. Its balance sheet should be honest enough to ask what protecting those conditions is worth.
Muskaan Muse Laroyia is a neuroscience researcher and co-founder of the Brain Climate & Equity Collaborative (Brain-CE) and a director of the Climate Health System Alliance at the University of Calgary’s O’Brien Institute for Public Health.
More on the topic here.
The Weekly Roundup
Get all our stories in one place, every Wednesday at noon EST.
